Evidence map›Paper›PMID 38269234›Full record

ReviewCureus2023

Insulin Resistance and Coronary Artery Disease: Untangling the Web of Endocrine-Cardiac Connections.

Fakhar Un Nisa Ashraf, Kashf Ghouri, Fnu Someshwar, Sunny Kumar, Narendar Kumar, Komal Kumari, Saira Bano, Saad Ahmad, Muhammad Hasnain Khawar, Lata Ramchandani and 5 more

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The impact of diabetes on giant negative T-wave amplitude in apical hypertrophic cardiomyopathy patients.American heart journal plus : cardiology research and practice · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Fakhar Un Nisa AshrafMedicine, The Royal Wolverhampton National Health Service (NHS) Trust, Wolverhampton, GBR.
Kashf GhouriEndocrinology, Mayo Hospital, Lahore, PAK.
Fnu SomeshwarMedicine, Liaquat National Hospital and Medical College, Karachi, PAK.
Sunny KumarMedicine, Liaquat National Hospital and Medical College, Karachi, PAK.
Narendar KumarInternal Medicine, Burjeel Hospital, Abu Dhabi, ARE.
Komal KumariMedicine, New Medical Centre (NMC) Royal Family Medical Centre, Abu Dhabi, ARE.
Saira BanoMedicine, Faisalabad Medical College and University, Faisalabad, PAK.
Saad AhmadMedicine, Shalamar Medical and Dental College, Lahore, PAK.
Muhammad Hasnain KhawarMedicine, Mayo Hospital, Lahore, PAK.
Lata RamchandaniMedicine, People's University of Medical and Health Sciences for Women, Nawabshah, PAK.
Tamara SalameMedicine, Wayne State University, Detroit, USA.
Giustino VarrassiPain Medicine, Paolo Procacci Foundation, Rome, ITA.
Mahima KhatriInternal Medicine/Cardiology, Dow University of Health Sciences, Civil Hospital Karachi, Karachi, PAK.
Satish KumarMedicine, Shaheed Mohtarma Benazir Bhutto Medical College, Karachi, PAK.
Tamam MohamadCardiology, Wayne State University, Detroit, USA.
Liaquat National Hospital · PKFondazione Roma · ITMayo Hospital · PKWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between insulin resistance and coronary artery disease (CAD) is a crucial study area in understanding the complex connection between metabolic dysregulation and cardiovascular morbidity. This scholarly investigation examines the intricate relationship between insulin resistance, a key characteristic of metabolic syndrome, and CAD development. The goal is to understand the detailed molecular and physiological connections that underlie the dangerous connection between the endocrine and cardiac systems. The recognition of insulin resistance as a key player in cardiovascular disease highlights the need to study the complex relationships between insulin signaling pathways and the development of atherosclerosis. This research analyzes the molecular processes by which insulin resistance leads to disruptions in lipid metabolism, inflammatory reactions, and malfunction of the blood vessel's inner lining. These processes create an environment that promotes the development and advancement of CAD. As we begin this scientific exploration, it becomes clear that insulin resistance acts as a metabolic indicator and a potent mediator of endothelial dysfunction, oxidative stress, and systemic inflammation. The complex interaction between insulin-sensitive tissues and the vascular endothelium plays a crucial role in defining the pathophysiological landscape of CAD. Furthermore, this discussion highlights the mutual interaction between the endocrine and cardiac systems, where CAD produced by myocardial ischemia worsens insulin resistance through complex molecular pathways. Discovering new therapeutic targets that disrupt the harmful cycle between insulin resistance and the development of CAD shows potential for creating specific therapies to reduce cardiovascular risk in people with insulin resistance. This study aims to clarify the complexities of the connection between the endocrine system and the heart, establishing the basis for a thorough comprehension of how insulin resistance contributes to the development and advancement of CAD.

Indexed as

atherosclerosiscardiovascular pathophysiologycoronary artery diseaseendocrine-cardiac connectionsinsulin resistancemetabolic syndrome

Identifiers

PMID38269234
PMCPMC10806385
OpenAlexW4390194654

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.